Prevalence and significance of mediastinal lymphadenopathy in patients with Severe Acute Respiratory Syndrome Corona Virus-2 infection

Eur Rev Med Pharmacol Sci. 2021 May;25(9):3607-3609. doi: 10.26355/eurrev_202105_25843.

Abstract

Severe Acute Respiratory Syndrome Corona Virus-2 is the causative factor of Coronavirus Disease 2019. Early in the pandemic, mediastinal lymphadenopathy was not considered to be a significant radiologic finding of the SARS-COV-2 disease. Nevertheless, most recent studies associate mediastinal lymphadenopathy with more severe COVID-19 disease and poorer patient outcomes.

Publication types

  • Review

MeSH terms

  • COVID-19 / diagnosis
  • COVID-19 / epidemiology*
  • COVID-19 / immunology
  • Humans
  • Lymphadenopathy / diagnosis
  • Lymphadenopathy / epidemiology*
  • Lymphadenopathy / immunology
  • Mediastinal Diseases / diagnosis
  • Mediastinal Diseases / epidemiology*
  • Mediastinal Diseases / immunology
  • Mediastinum / pathology
  • Prevalence
  • SARS-CoV-2* / immunology